4,5,6,7-Tetrahydro-1H-4,7-methanoindole-2-carboxylic acid, 97%, 100mg

3,3,9,9-Tetraethyl-4,8-dioxa-3,9-disilaundecan-6-one, 98%, 10g

[1-(1-methyl-1H-benzimidazol-2-yl)ethyl]amine dihydrochloride hydrate, 95.0%, 10g

2-(5-Amino-2H-indazol-2-yl)ethanol, 95.0%, 1g

Pipette microlitre monocanal mLINE® variable, 500 à 5000 µl, 1 pièce

(4-((2-(Piperidin-1-yl)ethyl)carbamoyl)phenyl)boronic acid hydrochloride, 95.0%, 1g

2-Fluorobenzonitrile, 98.0%, 500g

5-Formylthiophene-2-boronic acid, 97.0%, 1g

6-Cyclopropylnicotinic acid, 95.0%, 5g

3-(1-Benzothiophen-3-yl)propanoic acid, 97%, 500mg

3-Chlorobenzamide, 98.0%, 100g

Methyl 4-chloro-1-methyl-1H-pyrrolo[3,2-c]pyridine-7-carboxylate, 95.0%, 500mg

2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-amine, 95.0%, 500mg